MedTrace Logo

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

NCT05338333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2023-09-13

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to demonstrate noninferiority in visual acuity at distance when wearing the test contact lenses (LID210464) compared to the control contact lenses (AOHG MF) after 30 days of wear.

Conditions

Interventions

DEVICE

Lehfilcon A multifocal contact lenses

Investigational frequent replacement soft contact lens indicated for the optical correction of presbyopia

DEVICE

Lotrafilcon B multifocal contact lenses

Commercially available frequent replacement soft contact lens indicated for the optical correction of presbyopia

DEVICE

CLEAR CARE®

Hydrogen peroxide-based contact lens cleaning and disinfecting solution

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, Vision Care · Alcon Research, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-27
Primary Completion
2022-09-01
Completion
2022-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05338333 on ClinicalTrials.gov